MK-0812

DB11990InvestigationalSmall molecule

MK0812 has been used in trials studying the treatment of Relapsing-Remitting Multiple Sclerosis.

Chemical structure of MK-0812
Mechanism
Curator reviewed
Formula / weight
C24H34F3N3O3 · 469.549 g/mol (avg)
Code names
MK-0812

Resolves to

Structure
InChIKeyMTMDXAIUENDNDL-RJSMDTJLSA-NSMILESCO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](C1)(C(C)C)C(=O)N1CCC2=NC=C(C=C2C1)C(F)(F)F
Targets

What you can answer from here — as of November 05, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with MK-0812, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account